山东辰欣佛都药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
70
NMPA:70
Drug Approvals
Travoprost and Timolol Maleate Eye Drops
- Product Name
- 曲伏噻吗滴眼液
- Approval Number
- 国药准字H20254073
- Approval Date
- May 13, 2025
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20244431
- Approval Date
- Jul 9, 2024
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20244030
- Approval Date
- Jun 18, 2024
NMPA
Timolol Maleate Eye Drops
- Product Name
- 马来酸噻吗洛尔滴眼液
- Approval Number
- 国药准字H37022028
- Approval Date
- May 11, 2024
NMPA
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20243358
- Approval Date
- Mar 19, 2024
NMPA
Bromfenac Sodium Eye Drops
- Product Name
- 溴芬酸钠滴眼液
- Approval Number
- 国药准字H20233366
- Approval Date
- Mar 24, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found